1. Home
  2. SHO vs PGEN Comparison

SHO vs PGEN Comparison

Compare SHO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$11.36

Market Cap

1.8B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.55

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHO
PGEN
Founded
1995
1998
Country
United States
United States
Employees
37
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SHO
PGEN
Price
$11.36
$5.55
Analyst Decision
Hold
Buy
Analyst Count
7
5
Target Price
$9.79
$8.33
AVG Volume (30 Days)
3.1M
5.7M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
3.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$3.95
$1,115.92
Revenue Next Year
$2.30
$81.04
P/E Ratio
$966.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.52
$1.47
52 Week High
$12.07
$6.04

Technical Indicators

Market Signals
Indicator
SHO
PGEN
Relative Strength Index (RSI) 49.80 62.94
Support Level $8.81 $3.90
Resistance Level $12.07 N/A
Average True Range (ATR) 0.26 0.33
MACD -0.11 0.06
Stochastic Oscillator 23.04 69.02

Price Performance

Historical Comparison
SHO
PGEN

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: